Generics 'Urgently' Call On Fed. Circ. To Protect Skinny Labels
The Federal Circuit has turned a "safe harbor" that allows generic-drug makers to sell patent-protected drugs for off-patent uses into "dangerous waters," the generics industry told the full court Wednesday, backing...To view the full article, register now.
Already a subscriber? Click here to view full article